PDS Biotechnology Corporation (PDSB)
NASDAQ: PDSB · IEX Real-Time Price · USD
3.270
+0.010 (0.31%)
At close: Apr 26, 2024, 4:00 PM
3.360
+0.090 (2.75%)
After-hours: Apr 26, 2024, 7:39 PM EDT

PDS Biotechnology Ratios and Metrics

Millions USD. Fiscal year is Jan - Dec.
Year Current2023202220212020201920182017201620152014
Market Capitalization
120155376230481510289361360-
Market Cap Growth
--58.92%63.38%383.47%211.09%52.28%-96.52%-20.01%0.37%--
Enterprise Value
8712232616619310222270235-11
PE Ratio
-3.60-3.60-9.21-13.61-3.21-2.19-2.62-5.68-9.31-11.10-
PB Ratio
4.595.928.553.641.761.31-4.874.644.052.94-
P/FCF Ratio
-4.60-4.60-14.64-18.45-3.62-0.86-6.41-7.07-11.00-15.62-
P/OCF Ratio
-4.60-4.60-14.64-18.45-3.62-0.85-6.41-7.10-11.23-16.56-
EV/EBITDA Ratio
-2.84-2.84-7.87-7.81-1.32-0.43-2.65-4.34-6.86-8.310.89
EV/EBIT Ratio
-2.83-2.83-7.82-7.72-1.31-0.43-2.60-4.32-6.84-8.290.88
EV/FCF Ratio
-3.62-3.62-12.68-13.26-1.48-0.18-6.36-5.42-8.21-10.201.05
Debt / Equity Ratio
0.910.910.530.010.02--0.010.330.170.04-0.09
Debt / EBITDA Ratio
-0.56-0.56-0.57-0.02-0.04--0.01-0.40-0.38-0.19-0.21
Debt / FCF Ratio
-0.71-0.71-0.91-0.04-0.05--0.02-0.50-0.45-0.23-0.24
Quick Ratio
4.154.157.5217.378.824.350.056.8415.9215.163.53
Current Ratio
4.334.337.7917.809.285.180.066.9216.0615.283.94
Interest Coverage
-33.04-33.04-109.28---218.91-1066.17-23.51-32.79-34.75-68.83
Return on Equity (ROE)
-138.40%-138.40%-82.40%-29.60%-62.50%-38.70%-14.40%-67.80%-38.00%-68.50%63.80%
Return on Assets (ROA)
-69.00%-69.00%-60.80%-27.70%-54.30%-30.90%-9.50%-50.00%-33.30%-43.00%-107.80%
Return on Capital (ROIC)
-86.12%-86.12%-61.76%-33.66%-53.72%-179.82%179.07%-62.74%-37.91%-20.74%52.27%
Earnings Yield
-35.80%-27.78%-10.86%-7.35%-31.17%-45.70%-38.15%-17.59%-10.74%-9.01%-
FCF Yield
-28.04%-21.76%-6.83%-5.42%-27.60%-116.22%-15.61%-14.14%-9.09%-6.40%-
Buyback Yield / Dilution
-8.23%-8.23%-11.73%-52.86%-243.98%-45.87%-119.61%-5.30%-256.88%-379.01%-
Total Shareholder Return
-8.23%-8.23%-11.73%-52.86%-243.98%-45.87%-119.61%-5.30%-256.88%-379.01%-
Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).